International Edition
Latest News
Health

40% Higher Stroke Risk Linked to Occasional Cannabis Use

Tulane University Study Links Occasional Cannabis Use to Increased Stroke Risk An epidemiological analysis presented at the American Heart Association scientific sessions in Chicago reveals that consuming cannabis just one to five days per month is associated with…

40% Higher Stroke Risk Linked to Occasional Cannabis Use

Tulane University Study Links Occasional Cannabis Use to Increased Stroke Risk

An epidemiological analysis presented at the American Heart Association scientific sessions in Chicago reveals that consuming cannabis just one to five days per month is associated with a 40 percent higher risk of stroke compared to non-users. The findings, led by Professor Aabha Divya of Tulane University in New Orleans, draw on data from the Behavioral Risk Factor Surveillance System gathered between 2020 and 2024 across 16 to 24 U.S. states. Recreational legalization has driven the proportion of adult cannabis consumers up by 51 percent over a four-year period, reaching roughly one in six Americans. Yet the new clinical data challenge the assumption that casual consumption carries no cardiovascular consequences, highlighting severe vascular issues in patients averaging 49 years of age.

Surprising Divergence Between Occasional and Intensive Users

The data show a complex relationship between consumption frequency and cardiovascular outcomes. While occasional users face a 40 percent rise in stroke risk, that specific elevated risk drops to 25 percent among intensive users who consume cannabis 16 to 30 days per month. Across broader cardiovascular disease categories, the disparity persists: declaring a cardiovascular disease rises by 23 percent among light consumers, compared to 21 percent for daily users. However, researchers found no statistically significant link between consumption frequency and myocardial infarction within this specific cohort, despite prior studies connecting legalization to increased cardiac hospitalizations.

Equal Endothelial Damage Across Ingestion and Inhalation Methods

Ingesting THC gummies or other edibles offers no protection to blood vessel walls. The findings confirm that smoking, vaping, and eating cannabis products trigger identical endothelial alterations. To isolate these impacts, the research team adjusted for statistical biases including obesity, diabetes, chronic kidney disease, physical inactivity, income levels, and tobacco or alcohol consumption. Robert L. Page II, a clinical pharmacist at the University of Colorado, notes that the plant has long been wrongly overlooked as an innocent bystander among cigarette smokers.

Study Relies on Preliminary Telephone Surveys Subject to Recall Bias

The findings remain preliminary and have not yet undergone peer review. The study relies on telephone surveys subject to recall bias, and it cannot quantify exact THC doses or separate former users from the control group. This vascular warning accompanies other public health indicators released by the American Heart Association. Hypertension during the first 20 weeks of pregnancy raises a newborn’s congenital heart defect risk by 30 percent—a figure that reaches 48 percent if the mother has type 1 or type 2 diabetes. Meanwhile, Stanford physicians report a 15 percent quarterly rise in severe pediatric head injuries linked to e-bikes and electric scooters, with half of those incidents involving children under 12.

Frequently Asked Questions About Cannabis Vascular Research

Do edible cannabis products protect blood vessels better than smoking?

No, the study shows that the method of administration provides no protective effect. Whether the product is smoked, vaped, or ingested as food, the negative impact on blood vessel function and stroke risk remains identical, according to the Tulane University data presented at the American Heart Association sessions.

Why does the study report a correlation rather than direct causation?

The researchers analyzed observational data collected at a single point in time through telephone questionnaires across nearly half a million respondents. While this methodology establishes a strong statistical correlation, it cannot biologically track direct cause and effect or measure the exact concentration of THC in the products consumed.

What demographic profile defines the participants in this survey?

The sample comprises 442,906 American adults from 16 to 24 states that included the optional marijuana module in federal surveys between 2020 and 2024. Participants averaged 49 years of age, with an even gender split of approximately 50 percent women.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”